ALYSSA KORTSCHINSKY: Open Payments
NPI 1629473590 · WARWICK, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,554 in 203 payments from 16 companies in 2025. Trend: 2023 $48 · 2024 $3,483 · 2025 $4,554
Food & beverage: $4,554
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $762 |
| Otsuka America Pharmaceutical, Inc. | 27 | $614 |
| Vanda Pharmaceuticals Inc. | 23 | $555 |
| Alkermes, Inc. | 17 | $546 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $437 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $287 |
| Axsome Therapeutics, Inc. | 11 | $270 |
| Collegium Pharmaceutical, Inc. | 15 | $229 |
| Tris Pharma Inc | 11 | $187 |
| Janssen Pharmaceuticals, Inc | 6 | $171 |
Products named: REXULTI, VRAYLAR, FANAPT, CAPLYTA, LYBALVI, TRINTELLIX, Auvelity, Jornay PM.
Industry payments across RI — which companies pay providers there.
